Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T04:26:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3 instead of v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:43:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2 with no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:06:11.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A minor revision label changed from v3.4.0 to v3.4.1; no observable changes to core study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:54:06.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Page updates include a new Show glossary option and updated meta-data labels (Last Update Submitted that Met QC Criteria) and version text (Revision: v3.4.0), with some older labels (No FEAR Act data) removed or reformatted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:35:10.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no substantive changes to trial content, eligibility criteria, or results are observable. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:35.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.